| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7635a866e16f1aaa3890259b4b4e1c7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2005-08-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5b25c0c789544d8ffd561c1d9c2fba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad5085a69051e959a2628d5d081c50ce |
| publicationDate |
2006-05-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006110390-A1 |
| titleOfInvention |
Inhibition of Ku as a treatment for cardiovascular diseases |
| abstract |
The present invention provides for methods of treating and preventing cardiovascular diseases, in particular pathological cardiac hypertrophy and chronic heart failure, by applying an inhibitor of Ku. The present invention also provides for methods of screening to find inhibitors of Ku and inhibitors of cardiac hypertrophy and heart failure. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022079082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010019914-A3 |
| priorityDate |
2004-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |